Hollsteen
← Marvell

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 FY2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 FY2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 FY2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 FY2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 FY2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 FY2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 FY2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 FY2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 FY2021: $280M · 10-Q 0001835632-21-000010 filed Jun 9, 2021Research and development · Q2 FY2021: $277M · 10-Q 0001835632-21-000022 filed Aug 27, 2021Research and development · Q3 FY2021: $256M · 10-Q 0001835632-21-000032 filed Dec 3, 2021Research and development · Q4 FY2021: $260M · derived · 10-K 0001835632-22-000016 filed Mar 10, 2022Research and development · Q1 FY2022: $286M · 10-Q 0001835632-21-000010 filed Jun 9, 2021Research and development · Q2 FY2022: $367M · 10-Q 0001835632-21-000022 filed Aug 27, 2021Research and development · Q3 FY2022: $372M · 10-Q 0001835632-22-000053 filed Dec 2, 2022Research and development · Q4 FY2022: $399M · derived · 10-K 0001835632-23-000013 filed Mar 9, 2023Research and development · Q1 FY2023: $444M · 10-Q 0001835632-22-000028 filed May 27, 2022Research and development · Q2 FY2023: $449M · 10-Q 0001835632-22-000041 filed Aug 26, 2022Research and development · Q3 FY2023: $448M · 10-Q 0001835632-22-000053 filed Dec 2, 2022Research and development · Q4 FY2023: $443M · derived · 10-K 0001835632-24-000009 filed Mar 13, 2024Research and development · Q1 FY2024: $481M · 10-Q 0001835632-23-000029 filed May 26, 2023Research and development · Q2 FY2024: $475M · 10-Q 0001835632-23-000038 filed Aug 25, 2023Research and development · Q3 FY2024: $481M · 10-Q 0001835632-23-000046 filed Dec 1, 2023Research and development · Q4 FY2024: $460M · derived · 10-K 0001835632-25-000057 filed Mar 12, 2025Research and development · Q1 FY2025: $476M · 10-Q 0001835632-24-000063 filed May 31, 2024Research and development · Q2 FY2025: $487M · 10-Q 0001835632-24-000142 filed Aug 30, 2024Research and development · Q3 FY2025: $489M · 10-Q 0001835632-24-000200 filed Dec 4, 2024Research and development · Q4 FY2025: $499M · derived · 10-K 0001835632-26-000011 filed Mar 11, 2026Research and development · Q1 FY2026: $508M · 10-Q 0001835632-25-000117 filed May 30, 2025Research and development · Q2 FY2026: $519M · 10-Q 0001835632-25-000189 filed Aug 29, 2025Research and development · Q3 FY2026: $512M · 10-Q 0001835632-25-000197 filed Dec 3, 2025Research and development · Q4 FY2026: $536M · derived · 10-K 0001835632-26-000011 filed Mar 11, 2026Research and development · Q1 FY2027: $652M · 10-Q 0001835632-26-000019 filed May 28, 2026Research and development · Q2 FY2027: $741M · 10-Q 0001835632-26-000025 filed Aug 28, 2026missing512741280Q1 FY2016Q2 FY2027
$MResearch and development · Q3 FY2025: $489M · 10-Q 0001835632-24-000200 filed Dec 4, 2024Research and development · Q4 FY2025: $499M · derived · 10-K 0001835632-26-000011 filed Mar 11, 2026Research and development · Q1 FY2026: $508M · 10-Q 0001835632-25-000117 filed May 30, 2025Research and development · Q2 FY2026: $519M · 10-Q 0001835632-25-000189 filed Aug 29, 2025Research and development · Q3 FY2026: $512M · 10-Q 0001835632-25-000197 filed Dec 3, 2025Research and development · Q4 FY2026: $536M · derived · 10-K 0001835632-26-000011 filed Mar 11, 2026Research and development · Q1 FY2027: $652M · 10-Q 0001835632-26-000019 filed May 28, 2026Research and development · Q2 FY2027: $741M · 10-Q 0001835632-26-000025 filed Aug 28, 2026512741489Q3 FY2025Q2 FY2027Q3 FY2026
Q3 FY2026
512$M
All values (26)
PeriodValue ($M)Status
Q2 FY2027741reported
Q1 FY2027652reported
Q4 FY2026536derived
Q3 FY2026512reported
Q2 FY2026519reported
Q1 FY2026508reported
Q4 FY2025499derived
Q3 FY2025489reported
Q2 FY2025487reported
Q1 FY2025476reported
Q4 FY2024460derived
Q3 FY2024481reported
Q2 FY2024475reported
Q1 FY2024481reported
Q4 FY2023443derived
Q3 FY2023448reported
Q2 FY2023449reported
Q1 FY2023444reported
Q4 FY2022399derived
Q3 FY2022372reported
Q2 FY2022367reported
Q1 FY2022286reported
Q4 FY2021260derived
Q3 FY2021256reported
Q2 FY2021277reported
Q1 FY2021280reported

20 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: rnd

More metrics for Marvell

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$512M
Period
Q3 FY2026, ended Nov 1, 2025 · quarterly value (3 months, not cumulative)
Source
10-Q, filed Dec 3, 2025 · 0001835632-25-000197
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$512MDec 3, 202510-Q 0001835632-25-000197reported · confidence 1. · current